Humanetics Selects Lifecore Biomedical to Deliver CDMO Services Supporting Development of BIO 300 for the Prevention of Acute Radiation Syndrome
Provided By GlobeNewswire
Last update: Mar 17, 2025
Humanetics’ Novel Radioprotective Agent Being Developed with Funding from Department of Defense as Radiation Medical Countermeasure (MCM)
Lifecore to Carry Out Tech Transfer and Analytical Method Activities, including Filling of Pilot Batch
Read more at globenewswire.comNASDAQ:LFCR (4/22/2025, 1:40:53 PM)
6.14
+0.1 (+1.66%)
Find more stocks in the Stock Screener
LFCR Latest News and Analysis
18 days ago - ChartmillWhich stocks are experiencing notable movement on Friday?Stay up-to-date with the latest market trends in the middle of the day on Friday. Explore the top gainers and losers during today's session in our detailed report.
18 days ago - ChartmillWhich stocks are gapping on Friday?The market is filled with gapping stocks in Friday's session. Let's discover which stocks are showing gap-ups and gap-downs.
